David Abrams Abrams Capital Management
David Abrams is the founder of Abrams Capital Management, a Boston-based firm with a flexible value-oriented mandate. A former Baupost Group investor, he is known for concentrated positions and a willingness to hold cash or unconventional securities when public equities are unattractive. Abrams Capital’s filings are followed for high-conviction ideas across equities and special situations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$250M |
| 2 |
TransDigm Group
TDG
|
+$42.3M |
| 3 |
Coupang
CPNG
|
+$6.88M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 50.22% |
| 2 | Communication Services | 17.39% |
| 3 | Industrials | 14.03% |
| 4 | Energy | 6.51% |
| 5 | Financials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Lithia Motors
LAD
$8.15B
| $715M | 20.56% |
2,351,068
| – | – |
|
2
Asbury Automotive
ABG
$3.86B
| $507M | 14.58% |
2,108,540
| – | – |
|
|
3
Meta Platforms (Facebook)
META
$1.4T
| $327M | 9.39% |
1,138,126
-1,013,732
| -47% | -$250M |
|
|
4
TransDigm Group
TDG
$66.4B
| $280M | 8.04% |
312,747
-53,440
| -15% | -$42.3M |
|
|
5
Alphabet (Google) Class A
GOOGL
$4.22T
| $278M | 7.99% |
2,322,340
-17,100
| -0.7% | -$1.97M |
|
|
6
Coupang
CPNG
$29.6B
| $227M | 6.51% |
13,017,964
-422,000
| -3% | -$6.88M |
|
7
Energy Transfer Partners
ET
$73B
| $226M | 6.51% |
17,834,322
| – | – |
|
8
Willis Towers Watson
WTW
$31.8B
| $190M | 5.46% |
806,836
| – | – |
|
9
U-Haul Holding Co Series N
UHAL.B
$12.3B
| $186M | 5.34% |
3,663,243
| – | – |
|
10
Camping World
CWH
$676M
| $154M | 4.42% |
5,108,808
| – | – |
|
|
SGI
11
Somnigroup International
SGI
$13.6B
| $144M | 4.15% |
3,600,000
| – | – |
|
|
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $91.6M | 2.64% |
+890,993
| New | +$94M |
|
13
Teva Pharmaceuticals
TEVA
$43.5B
| $60M | 1.73% |
7,966,433
| – | – |
|
|
CTLP
14
DELISTED
Cantaloupe
CTLP
| $57.2M | 1.64% |
7,180,000
| – | – |
|
|
15
U-Haul Holding Co
UHAL
$13.9B
| $22.5M | 0.65% |
407,027
| – | – |
|
16
Nuvation Bio
NUVB
$2.43B
| $6.86M | 0.2% |
3,811,513
| – | – |
|
17
USCB Financial Holdings
USCB
$415M
| $6.62M | 0.19% |
649,085
| – | – |
|
Similar funds
David Abrams's Q2 2023 Portfolio in Review
As of Q2 2023, David Abrams held 17 positions worth $3.48B, up 10% from $3.16B the previous quarter. Its ten largest holdings account for 89% of the portfolio.
David Abrams withdrew a net $207M in Q2 2023, reducing 4 holdings. Its largest reduction was Meta Platforms (Facebook), cutting an estimated $250M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 46% a quarter earlier, followed by Communication Services and Industrials.
Against the trend, David Abrams opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $91.6M.
- David Abrams's largest Q2 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 890,993 shares worth $91.6M.
- David Abrams's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $250M.
- David Abrams's ten largest holdings make up 89% of its $3.48B portfolio in Q2 2023.
- David Abrams opened 1 new position and closed 0 in Q2 2023.
- David Abrams's portfolio value rose 10% quarter-over-quarter to $3.48B.
Based on Abrams Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.